trending Market Intelligence /marketintelligence/en/news-insights/trending/-ea4tIe1UdVA3qD3-pC_UQ2 content esgSubNav
In This List

Lattice Biologics COO, director resign

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Lattice Biologics COO, director resign

Darrell Holmes resigned as the COO of Lattice Biologics Inc. to pursue other commercial opportunities, effective Dec. 1.

In addition, Mario Stifano resigned as director due to conflicting time priorities, effective Dec. 12.

Both Holmes and Stifano are eligible to act as an adviser or consultant to Lattice Biologics, and the company may elect to retain their services in the future.